← feed

Is NCT03125473 results overdue?

Yes — results are overdue. Primary completion was 2017-07-01; the FDAAA-801 reporting deadline (2018-07-01) passed 2912 days ago and no results are posted on ClinicalTrials.gov.

Dose-Optimization Trial of VXA-G1.1-NN in Healthy Volunteers

NCT IDNCT03125473 ↗
SponsorVaxart (INDUSTRY)
Public issuerVaxart, Inc. — VXRT (CIK 0000072444) best-effort name match, 95% conf — verify on EDGAR ↗
PhasePHASE1
StatusCOMPLETED
Primary completion2017-07-01 (ACTUAL)
Reporting deadline2018-07-01 (completion + 365d)
Days overdue2912
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 1d1a1ebf9bb8bc2a… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03125473. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →